Pops & Drops: Home Depot, WellPoint
Following are the day's biggest winners and losers. Find out why shares of Home Depot and Tupperware popped while Legg Mason and Novartis dropped.
POPS (stocks that jumped higher)
State Street (STT) popped 31%. The global money manager popped after reporting private equity assets rose 60% last year; also investors thought State Street would benefit from Obama’s 'bad bank' plan. - After a 31% gain, take profits! exclaims Jeff Macke.
Lloyds Banking Group (LYG) popped 66%. The British mortgage lender popped as Citigroup upgraded the stock relieving investors’ concerns over how much money the bank will need. - I wouldn't be selling them, says Tim Seymour.
WellPoint (WLP) popped 4%. The major U.S. health insurer popped after reporting medical costs increased less than analysts had expected, indicating the recession could potentially help moderate health care costs. - Health insurers in general have had a huge run so far this year, Karen Finerman points out.
Home Depot (HD) popped 4%. The global retailer popped along with consumer and housing stocks on hopes the economic stimulus will get passed. - They're sticking to their guns... they've gotten rid of some stores and I think they'll continue the trend, says Jeff Macke.
Hartford Financial Services (HIG) popped 21%. The firm rose after state insurance commissioners backed proposals to loosen capital requirements, which may lead to a change in reserve rules for the insurers. - They're probably going to ease the capital requirements on insurers, but the sector looks challenging, says Tim Seymour.
Tupperware Brands (TUP) popped 7%. The producer of specialty containers popped as investors flocked to the stock as a recession-play. - In a recession, people use Tupperware to help cut food costs, says Jeff Macke.
DROPS (stocks that slid lower)
Legg Mason (LM) dropped 7%. The money manager dropped after reporting its largest loss in 25 years due in part to huge withdrawals and writedowns. - Assets under management are dwindling, which is not good for Legg's business, says Guy Adami.
Amylin Pharmaceuticals (AMLN) dropped 9%. The firm fell after fourth-quarter losses were worse than expected, due to a slide in sales of its diabetes drug Byetta, along with restructuring costs. - The quarter wasn't that bad, says Adami.
Novartis (NVS) dropped 5%. The European drug maker dropped as profits fell below estimates in the fourth-quarter, due to the strong dollar and restructuring costs. The company's expected meningitis vaccine will also be delayed until 2011.
Got something to to say? Send us an e-mail at email@example.com and your comment might be posted on the Rapid Recap! If you'd prefer to make a comment but not have it published on our website send your e-mail to firstname.lastname@example.org.
Trader disclosure: On Jan 28, 2009, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Macke Owns (BAC), (MSFT), (MS), (TM), (MCD); Seymour Owns (AAPL), (BAC), (EEM), (F), (FXI); Adami Owns (AGU), (C), (BTU), (GS), (INTC), (MSFT), (NUE); Finerman's Firm Owns (MSFT), (UNH); Finerman's Firm Owns (DNA) & (DNA) Call Spread; Finerman's Firm Is Short (IYR), (IJR), (IWM), (MDY), (SPY), (COF), (USO)